Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Adenocarcinoma and NQO1[original query] |
---|
Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Aug 11 (8): 730-8. Sunaga Noriaki, Kohno Takashi, Yanagitani Noriko, Sugimura Haruhiko, Kunitoh Hideo, Tamura Tomohide, Takei Yoshikazu, Tsuchiya Satoshi, Saito Ryusei, Yokota J |
Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. International journal of cancer. Journal international du cancer 2003 Nov 107 (3): 381-6. Sarbia Mario, Bitzer Monika, Siegel David, Ross David, Schulz Wolfgang A, Zotz Rainer B, Kiel Sybille, Geddert Helene, Kandemir Yasemin, Walter Alexandra, Willers Reinhart, Gabbert Helmut |
NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World journal of gastroenterology : WJG 2003 Jul 9 (7): 1390-3. Zhang Jian-Hui, Li Yan, Wang Rui, Geddert Helen, Guo Wei, Wen Deng-Gui, Chen Zhi-Feng, Wei Li-Zhen, Kuang Gang, He Ming, Zhang Li-Wei, Wu Ming-Li, Wang Shi-J |
Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung cancer (Amsterdam, Netherlands) 2003 May 40 (2): 123-9. Lin Pinpin, Hsueh Yu-Mei, Ko Jiunn-Liang, Liang Yu-Fei, Tsai Kan-Jen, Chen Chih- |
Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects. Gynecologic oncology 2005 Feb 96 (2): 423-9. Niwa Yoshimitsu, Hirose Kaoru, Nakanishi Toru, Nawa Akihiro, Kuzuya Kazuo, Tajima Kazuo, Hamajima Nobuyu |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 May 15 (5): 979-87. Chao Chun, Zhang Zuo-Feng, Berthiller Julien, Boffetta Paolo, Hashibe M |
The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genetics in medicine : official journal of the American College of Medical Genetics 2007 Jun 9 (6): 341-7. di Martino Erica, Hardie Laura J, Wild Christopher P, Gong Yun Y, Olliver Joanna R, Gough Martin D, Bird Nigel |
Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2009 Jul . Song SY, Jeong SY, Park HJ, Park SI, Kim DK, Kim YH, Shin SS, Lee SW, Ahn SD, Kim JH, Lee JS, Choi EK |
Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. DNA and cell biology 2011 May 30 (5): 297-303. Malik Manzoor Ahmad, Zargar Showkat Ali, Mittal Balr |
Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in Asians. Genetics and molecular research : GMR 2012 11 (3): 2328-37. Zhang Y, Wang Z T, Zhong |
Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis. Molecular biology reports 2012 Sep 39 (9): 9095-104. Malik Manzoor Ahmad, Zargar Showkat Ali, Mittal Balr |
EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients. International journal of cancer. Journal international du cancer 2013 Jan 132 (2): 2. Yang SY, Yang TY, Li YJ, Chen KC, Liao KM, Hsu KH, Tsai CR, Chen CY, Hsu CP, Hsia JY, Chuang CY, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Hsiung CA, Shen CY, Chang GC, Yang PC, Chen CJ |
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec 34 (6): 3967-79. Lou Yuqing, Li Rong, Xiong Liwen, Gu Aiqin, Shi Chunlei, Chu Tianqing, Zhang Xueyan, Gu Ping, Zhong Hua, Wen Shaojun, Han Baoh |
NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis. BMC medical genetics 2013 14 . Yanling H, Yuhong Z, Wenwu H, Lei X, Mingwu C |
Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer. Cell & bioscience 2015 5 53. Zhang Jialing, Yan Bin, Späth Stephan Stanislaw, Qun Hu, Cornelius Shaleeka, Guan Daogang, Shao Jiaofang, Hagiwara Koichi, Van Waes Carter, Chen Zhong, Su Xiulan, Bi Yong |
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma. Translational lung cancer research 2021 4 10 (3): 1327-1337. Patiño-García Ana, Guruceaga Elizabeth, Segura Victor, Sánchez Bayona Rodrigo, Andueza Maria Pilar, Tamayo Uria Ibon, Serrano Guillermo, Fusco Juan Pablo, Pajares María José, Gurpide Alfonso, Ocón Marimar, Sanmamed Miguel F, Rodriguez Ruiz Maria, Melero Ignacio, Lozano Maria Dolores, de Andrea Carlos, Pita Guillermo, Gonzalez-Neira Anna, Gonzalez Alvaro, Zulueta Javier J, Montuenga Luis M, Pio Ruben, Perez-Gracia Jose Lu |
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
- Page last reviewed:Feb 1, 2024
- Content source: